Skip to main content
Clinical Trials/NL-OMON39876
NL-OMON39876
Completed
N/A

An alternative approach for treatment of infantile esotropia with botulinum toxin A. - Botox in infantile esotropia.

Oogziekenhuis Rotterdam0 sites40 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Oogziekenhuis Rotterdam
Enrollment
40
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Oogziekenhuis Rotterdam

Eligibility Criteria

Inclusion Criteria

  • \- Infantile esotropia; age \< 6 years,
  • \- No known/established neurological disease.
  • \- No vertical deviation (no upshoots).
  • \- Non\-accommodative (less than 3D spherical equivalent hyperopia).
  • \- Up to 40 \* esotropia.
  • \- Free alternators.
  • \- Difference in refraction between both eyes \* 1\.5 D.

Exclusion Criteria

  • \- Previous strabismus surgery.
  • \- Retinal disease.
  • \- Any medical condition that would preclude general anesthesia with sevoflurane.
  • \- Hypersensitivity to any Botox ingredient.
  • \- Muscular disease such as myasthenia gravis or Eaton\-Lambert syndrome.

Outcomes

Primary Outcomes

Not specified

Similar Trials